跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,970 条关于
“Fresenius Kabi AG”
全部
1,970
临床试验
579
药物
474
机构
327
资讯
590
去年
Health Coaching Improves Health Information Literacy in CKD Patients: A Randomized Trial
去年
Formycon Halts Phase III Trial of FYB206 Following FDA Feedback, Faces Market Challenges for Biosimilars
去年
Fresenius Kabi Launches 30 mg/30 mL Epinephrine Injection for Emergency Care and Septic Shock
去年
Otulfi (Ustekinumab) Biosimilar Gains Regulatory Approvals in Canada and the UK for Inflammatory Diseases
6年前
Vifor Pharma and Fresenius Kabi Form Strategic Alliance to Address Iron Deficiency in China
2个月前
Dr Reddy's Secures US FDA Approval for Rituximab Biosimilar, Fresenius Kabi to Commercialize
去年
Amgen and Fresenius Kabi Reach Settlement in Denosumab Biosimilar Litigation
去年
Pacira BioSciences Settles EXPAREL Patent Litigation with Fresenius Kabi, Securing Market Exclusivity Until 2030
去年
FDA Approves Otulfi, a Stelara Biosimilar, for Inflammatory Conditions
去年
Fresenius Kabi Launches Epinephrine Injection, USP Expanding ...
第 1 页,共 59 页
上一页
下一页